US$ 27.08
is retatrutide a glp 1 drug Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, CBS News investigation Understanding the Next-Gen Weight Loss
Description
FOR REGULATE BLOOD SUGAR AND CURB APPETITE SOURCE 1: DailyMed

Diabetes Obesity and Metabolism

The current recommendation is to stop semaglutide at least 2 months before planned pregnancy and tirzepatide at least 1 month before

Diabetes Complications 30 , 16511658 (2016)
But what it found was not ambiguous

To avoid misconceptions, it is important to clarify that a GLP-1 booster: It is nutritional support that may help promote steadier blood-sugar responses when used consistently